NCT07743333CompletedPhase 4
Nebulized Lidocaine And Ketamine Before Fiberoptic Bronchoscopy
Nebulized Lidocaine And Ketamine As Premedication Before Fiberoptic Bronchoscopy: A Case-Control Study
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
The current study is looked for the comparison between nebulized lidocaine and ketamine, nebulized lidocaine, and usual lidocaine spray in the oral and nasal cavities before flexible bronchoscopy. The investigators are looking for different outcomes including mainly cough suppression during the procedure, patient tolerance and discomfort, operator and patients' satisfaction, and safety of the use of these medications especially regarding nebulized ketamine.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 134 (actual)
- First submitted
- 14 Jul 2026
- Start date
- 1 Sept 2024
- Primary completion date
- 28 Feb 2025
- Lead sponsor
- Alexandria University
- Diseases
- Lung cancer
- NCT number
- NCT07743333
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 134
- From 1 Sept 2024 to the primary completion date, 28 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- hypoxemia that is not corrected by oxygen therapy,
Other illness
- unstable angina or recent myocardial infarction,
- increased intracranial pressure or recent cerebrovascular stroke,
- uncontrolled hypertension,
- current viral infections or colds,
- history of allergy to lidocaine or ketamine,
Other
- uncontrolled uraemia,
- altered mental status, or
- non-corrected coagulopathy
Who the study is looking for
- All patients were assigned for FOB for diagnostic causes as part of their usual care.
- All patients were assigned for FOB for therapeutic causes as part of their usual care.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Alexandria University Faculty of Medicine Coordinator of this site? Confirm its status | Alexandria | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.